Skip to Main Content Skip to Search This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Chemours Stock Drops. Here's Why. By Al Root Nov 07, 2025, 11:33 am EST Share Resize Reprints In this article CC SPX DJIA Sometimes growth in one business can't overcome declines in anoth ...

The Chemours Company (NYSE:CC) Q3 2025 Earnings Call November 07, 2025 08:00 AM ET Speaker1Morning. My name is Gigi, and I'll be your conference operator today. I would like to welcome everyone to the Chemours Company third quarter 2025 results conference call. Currently, all participants are in listen-only mode. A question-and-answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded. I would now like to hand the conferenc ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

业绩总结 - 第三季度净销售额为15亿美元，同比下降0.9%[8] - 调整后EBITDA为1.95亿美元，同比下降3.5%[8] - 调整后净收入为3000万美元，同比下降50.8%[8] - 每股收益（EPS）为0.40美元，较去年同期的-0.22美元增长[8] - 自由现金流为1.05亿美元，同比增长66.7%[8] - 现金流转化率为54%，较去年同期的31%提升23个百分点[8] - 2023年第四季度公司总净销售额为13.68亿美元，较第三季度下降了7.5%[59] - 2023年第四季度公司调整后EBITDA为2.53亿美元，较第三季度增长了25.2%[61] - 2023年第四季度公司GAAP净收入为6000万美元，每股收益为0.40美元[61] - 2023年第四季度公司调整后净收入为3000万美元，每股收益为0.20美元[61] 用户数据 - Opteon制冷剂的净销售额同比增长80%[7] - 2024年第三季度，Opteon制冷剂的销量同比增长8%，主要受美国AIM法案下的固定空调需求推动[44] - 2024年第三季度，TSS部门的净销售额为1.39亿美元，Freon制冷剂占比从42%降至20%[43] 未来展望 - 预计到2025年底实现约1.25亿美元的成本节约[31] - 预计2025年第四季度净销售额将在57亿美元至58亿美元之间[39] - 调整后的EBITDA预计在7.45亿美元至7.7亿美元之间[39] - 预计2025年净销售额将按季度下降10%至15%[40] - 预计2025年自由现金流转化率将在50%至70%之间[40] - 2025年预计调整后净收入在1.27亿至1.44亿美元之间[68] - 2025年预计调整后EBITDA在7.45亿至7.70亿美元之间[68] 财务状况 - 总流动性为16亿美元，包括6.13亿美元的无限制现金和9.53亿美元的循环信贷额度[21] - 净债务为36亿美元，TTM净杠杆率为4.6倍[21] - 2025年第三季度的总债务为41.85亿美元，较2024年第二季度的40.78亿美元增加约2.6%[63] - 2025年第三季度的净杠杆比率（基于GAAP收益）为-17.1倍，而2024年第二季度为112.3倍[63] - 2025年第三季度的自由现金流为1.05亿美元，较2024年第三季度的6300万美元增长约66.7%[66] - 2025年第三季度的现金流来自经营活动为1.46亿美元，较2024年第三季度的1.39亿美元增长约5%[66] - 预计2025年利息支出为2.73亿美元[68] 部门表现 - 2024年第三季度，TT部门的净销售额同比下降8%，主要由于全球价格下降[49] - APM部门的净销售额同比下降12%，主要由于15%的销量下降[52] - 2023年第四季度，热能与专业解决方案部门的净销售额为3.80亿美元，较第三季度下降了14.5%[59] - 钛技术部门在2023年第四季度的净销售额为6.51亿美元，较第三季度下降了5.6%[59] - 高级性能材料部门在2023年第四季度的净销售额为3.26亿美元，较第三季度下降了6.6%[59]

文章核心观点 - 材料板块中相对强弱指数低于或接近30的股票被视为超卖状态，可能代表买入估值偏低公司的机会 [1][2] 超卖股票列表 - 根据RSI指标筛选出的主要超卖股票包括SunCoke Energy Inc、Rayonier Advanced Materials Inc和Chemours Co [2][3][4][5] SunCoke Energy Inc (SXC) 分析 - 公司第三季度调整后EBITDA为5910万美元，业绩超预期，但国内焦炭业务受到合同与现货销售组合不利的影响 [8] - 股价在过去一个月下跌约21%，52周低点为6.62美元，周四股价进一步下跌4.5%至6.64美元收盘 [8] - 当前RSI值为29.7，处于超卖区间 [8] Rayonier Advanced Materials Inc (RYAM) 分析 - 公司第三季度业绩未达预期，但管理层强调核心业务实力和团队执行力 [8] - 股价在过去一个月下跌约22%，52周低点为3.35美元，尽管近期下跌，但周四股价上涨1%至6.01美元收盘 [8] - 当前RSI值为29.5，处于超卖区间 [8] Chemours Co (CC) 分析 - 公司第三季度盈利低于预期，但管理层表示 consolidated results exceeded our expectations for the quarter，主要受Opton产品需求强劲推动 [8] - 股价在过去一个月下跌约26%，52周低点为9.13美元，周四股价下跌2.6%至11.74美元收盘 [8] - 当前RSI值为28.8，为三家公司中最低，处于超卖区间 [8]

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players in ...

Chemours (CC) reported $1.5 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.4%. EPS of $0.20 for the same period compares to $0.40 a year ago.The reported revenue represents a surprise of +0.19% over the Zacks Consensus Estimate of $1.49 billion. With the consensus EPS estimate being $0.24, the EPS surprise was -16.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street exp ...

Chemours (CC) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16.67%. A quarter ago, it was expected that this chemical company would post earnings of $0.46 per share when it actually produced earnings of $0.58, delivering a surprise of +26.09%.Over the last four quarters, the company ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) (State or other Jurisdiction of Incorporation or Organization) Delaware 46-4845564 (I.R ...

EXHIBIT 99.1 The Chemours Company Reports Third Quarter 2025 Results Wilmington, Del., November 6, 2025 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the third quarter 2025. Key Third Quarter 2025 Results & Highlights 1 "Our consolidated results exceeded our expectations for ...